Actin binding LIM 1 (abLIM1) is a cytoskeletal actin-binding protein that has been implicated in interactions between actin filaments and cytoplasmic targets. Previous biochemical and cytochemical studies have shown that abLIM1 interacts and co-localizes with F-actin in the retina and muscle. However, whether abLIM1 regulates osteoclast differentiation has not yet been elucidated. In this study, we examined the role of abLIM1 in osteoclast differentiation and function. We found that abLIM1 expression was upregulated during receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclast differentiation, and that a novel transcript of abLIM1 was exclusively expressed in osteoclasts. Overexpression of abLIM1 in the murine monocytic cell line, RAW-D suppressed osteoclast differentiation and decreased expression of several osteoclast-marker genes. By contrast, small interfering RNA-induced knockdown of abLIM1 enhanced the formation of multinucleated osteoclasts and markedly increased the expression of the osteoclast-marker genes. Mechanistically, abLIM1 regulated the localization of tubulin, migration, and fusion in osteoclasts. Thus, these results indicate that abLIM1 negatively controls osteoclast differentiation by regulating cell migration and fusion mediated via actin formation.
Introduction
Actin binding LIM 1 (abLIM1) is a cytoskeletal actin-binding protein that encodes a LIM zinc-binding domain at the N-terminus and dematin-like domain at the C-terminus. abLIM1
was initially discovered as a protein homologous to dematin that mediates interactions between actin filaments and cytoplasmic targets (Kim et al., 1997; Roof et al., 1997) .
Studies using cDNA libraries revealed that abLIM1 is mainly distributed as three distinct isoforms: abLIM1-L (long), abLIM1-M (middle), and abLIM1-S (short), respectively (Roof et al., 1997) . Moreover, the findings that abLIM1 biochemically interacts with F-actin, and cytochemically co-localizes with F-actin in the retina indicate that abLIM1 possibly regulates the actin cytoskeleton in the retina (Roof et al., 1997) . However, abLIM1-L knockout mice have been shown to display no phenotypes of retinal development and maturation, suggesting that abLIM1-L is not essential for retinal development (Lu et al., 2003) . Subsequently, a genetic study involving humans has shown abnormal splicing of abLIM1 in the skeletal muscles of patients with myotonic dystrophy type 1, which is characterized by muscle weakness and cardiac defects (Ohsawa et al., 2015) . Although abLIM1 is probably involved in the regulation of actin cytoskeleton in mammalian cells, the physiological role of abLIM1 has not been elucidated. Here, we demonstrate the role of abLIM1 in osteoclasts.
Osteoclasts are bone resorbing giant cells that have multinucleated formations (Teitelbaum, 2000) . The multinucleations are formed by the fusion of mononuclear progenitors of the monocyte/macrophage lineage (Boyle et al., 2003) . This process is strictly controlled by various factors. Initially, stimulation of mononuclear progenitors with the essential differentiation cytokines [macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappa-B ligand (RANKL)] induces release of F o r P e e r R e v i e w 4 chemokines, including CXCL12 (stromal cell-derived factor-1), CX3CL1 (fractalkine), and related molecules that are activated around other precursor cells (Ishii et al., 2010) .
Subsequently, these chemokines enhance migration and aggregation of cells adjacent to the secreted cells (Kikuta and Ishii, 2013) . Finally, the aggregated cells undergo cell-cell fusion through the key molecules on the plasma membrane, including DC-STAMP, SIRP-a/CD47, and E-cadherin (Fiorino and Harrison, 2016; Lundberg et al., 2007; Yagi et al., 2006) . In particular, DC-STAMP-deficient osteoclast-precursor cells lack multinucleation owning to cell-cell fusion defects (Yagi et al., 2005) . Recently, it has been proposed that actin-mediated cell extension formation of pre-osteoclasts termed as "fusopods" is essential for the cell fusion process of osteoclast differentiation (Wang et al., 2015) . Although regulation of the actin cytoskeleton is important for polarization, adhesion, and migration of osteoclasts, the mechanisms by which actin mediates the regulation of osteoclasts remain largely unknown.
To explore these mechanisms, we conducted DNA microarray analysis, which indicated that 1,363 genes were upregulated and 881 genes were downregulated during osteoclastogenesis (Shimada-Sugawara et al., 2015) . During a series of experiments involving osteoclasts, we found abLIM1 to be an upregulated gene. In this study, by using w 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w 6 FBS in the presence of M-CSF (50 ng/mL) at 37 °C in 5% CO 2 . Non-adherent cells were harvested to stroma-free bone marrow cell culture system containing 50 ng/mL M-CSF.
After three days, the adherent cells were harvested as BMMs. BMMs were replated and further cultured in the presence of M-CSF (30 ng/mL) and RANKL (100 ng/mL) for 72 h.
Retrovirus construction and overexpression of abLIM1
Retrovirus construction and overexpression experiments were performed according to previously described methods (Yamaguchi et al., 2017) . Briefly, the full-length cDNA of mouse abLIM1-OCL was generated by polymerase chain reaction (PCR) using cDNA derived from BMMs incubated with M-CSF and RANKL for 48 h. The cDNAs were amplified by PCR using PrimeSTAR GXL DNA polymerase (Takara, Tokyo). To express EGFP-abLIM1-OCL fusion protein, the amplified fragments were fused to a linearized pMSCVpuro-EGFP using the In-Fusion cloning kit (Clontech, Mountain View, CA, USA).
A control vector was composed with only EGFP cDNA. All vectors placed EGFP at its N terminus. Vectors were transfected into HEK293T cells by using the Lipofectamine 2000 kit (Life Technologies, Gaitherburg, MD, USA), according to the manufacturer's instructions. After incubation at 37 °C in 5% CO2 for 48 h, the virus-containing supernatants were collected and used to infect RAW-D cells. abLIM1-OCL overexpressing cells were selected by puromycin (3 µg/mL) in α-MEM and every 3 days, media was removed and new media added. About 2 weeks later, several cloned cells were obtained.
Western blot analysis
Western blotting was performed according to previously described methods (Yamaguchi et al., 2017) . Briefly, after washing, cells were lysed in a cell lysis buffer (50 mM Tris-HCl 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   7 [pH 8.0], 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 1 mM PMSF, and proteinase inhibitor cocktail). The same protein amounts (5 µg) were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, followed by transfer onto a polyvinylidene difluoride membrane. The blots were blocked with 5% milk in Tris-buffered saline for 1 h at 25°C, incubated with various primary antibodies overnight at 4°C, washed, incubated with horseradish peroxidase-conjugated secondary antibodies, and finally detected with ECL-Prime (GE Healthcare Life Sciences, Tokyo, Japan). The immunoreactive bands were analyzed using an LAS-4000mini (Fujifilm, Tokyo, Japan).
Quantitative PCR analysis
Quantitative real-time PCR was performed according to previously described methods (Yamaguchi et al., 2017; Yoneshima et al., 2016) . Total RNA was extracted using TRIzol Reagent (Invitrogen). Reverse transcription was performed using an oligo(dT)15 primer (Promega, Madison, WI, USA) and ReverTra Ace (Toyobo, Osaka, Japan). Quantitative real-time PCR was performed using a MX3005P QPCR system (Agilent Technologies, La Jolla, CA, USA). The cDNA was amplified using Brilliant III Ultra-Fast SYBR QPCR Master Mix (Agilent), according to the manufacturer's instructions. The following primer sets were used (5′ to 3′): abLIM1, forward: TGCTTCGCCTGTACAATCTG; and reverse: Control Duplexes (Invitrogen) were used as negative control.
Immunofluorescence microscopy
Immunofluorescence microscopy was performed according to previously described methods (Yamaguchi et al., 2017) . Briefly, cells were fixed with 4.0% paraformaldehyde in phosphate buffered saline (PBS) for 30 min at 25 °C. After washing, the fixed cells were nuclear staining with DAPI. The samples were subjected to microscopy using a laser-scanning confocal imaging system (LSM800; Carl Zeiss, AG, Jena, Germany).
Bone resorption assay
The bone resorption activity of osteoclasts was performed using Osteo Assay Stripwell Plate (Corning) for 6 days of culture. Images for bone resorption area were taken with a CKX41 Inverted Microscope (OLYMPUS). Resorption pits were identified using ImageJ software (NIH, Bethesda, MD, USA).
Live cell imaging
Live cell imaging was performed as described previously (Iwatake et al., 2017) . Briefly, images were obtained using an inverted Real-Time Cultured Cell Monitoring System CCM-1.4Z (ASTEC, Fukuoka, Japan) with a 10× objective and bright-field channels at 15-min intervals over up to 24 h for macrophage and 15-min intervals over up to 3 days for osteoclasts. Cell tracking analysis for migration was performed manually using the tracking function of the MTrackJ plugin of ImageJ.
Statistical analysis
All values were expressed as means ± standard deviation (SD) of 3 independent experiments. The data were analyzed by the Tukey-Kramer method when analysis of variance (ANOVA) indicated a significant difference between concentrations (*P < 0.05 or **P < 0.01).
Results

Identification of a novel transcript of abLIM1 during osteoclast differentiation
Our recent study using DNA microarray analysis showed that 1,363 genes were upregulated and 881 genes were downregulated during osteoclastogenesis of bone-marrow macrophages (Shimada-Sugawara et al., 2015) . Based on the data, we found the abLIM1 gene to be upregulated, as well as other osteoclast marker genes, such as calcitonin receptor, cathepsin K, carbonic anhydrase 2, and tartrate-resistant acid phosphatase (TRAP) ( Previous studies reported that abLIM1 is expressed in various tissues as three major forms; abLIM1-L (long), abLIM1-M (middle), and abLIM1-S (short) (Roof et al., 1997) ( Fig. 1C) . Therefore, we examined the abLIM1 transcript(s) expressed in osteoclasts.
Analysis of the PCR data and the deduced cDNA sequences revealed that the transcript of abLIM1 expressed in osteoclasts was a unique transcript, similar to abLIM1-M, and thus (Fig. 1C) . However, no other transcripts were detected.
Overexpression of abLIM1 suppresses multinucleation of osteoclasts
To explore the physiological roles of abLIM1 during osteoclastogenesis, we conducted overexpression experiments with a vector encoding abLIM1-OCLs-enhanced green fluorescent protein (EGFP) or EGFP alone ( Under these conditions, we examined the effects of abLIM1 on osteoclastogenesis with RANKL (100 ng/mL) by TRAP staining and multinucleated cell (MNC) formation (more than 3 nuclei). TRAP staining revealed that abLIM1 overexpression abolished osteoclast differentiation upon stimulation with RANKL for 4 days ( However, the viability of control and abLIM1-overexpressing osteoclasts was indistinguishable, although it was slightly increased in abLIM1-overexpressing osteoclasts (Fig. 2E ). We further examined bone resorption of control and abLIM1-overexpressing osteoclasts by the pit formation assay. Upon determining the resorption areas in both types, the resorption area by abLIM1-overexpressing osteoclasts was hardly detected, while that by control osteoclasts occupied approximately 3 % of the total area (Fig. 2F) . The calculated data of the resorption area in both types was shown in Fig. 2G . These results indicate that the reduced resorption area is probably owing to the abolished multinucleated formation in abLIM1-overexpressing osteoclasts.
abLIM1 overexpression reduces resorption area
abLIM1 overexpression decreases marker gene expression of osteoclasts
To determine whether abLIM1-overexpressing osteoclasts display impaired differentiation, we measured the mRNA levels of some osteoclast-marker genes in control and abLIM1-overexpressing osteoclasts (Fig. 3) . Quantitative RT-PCR analysis of 8 types of osteoclast-marker genes showed that mRNA levels of all marker genes, such as
(cathepsin K) and CALCR (calcitonin receptor) were significantly lower in abLIM1-overexpressing osteoclasts compared to those of control cells (Fig. 3) . These results suggest that expression of all osteoclast marker genes is reduced in abLIM1-overexpressing osteoclasts compared to control osteoclasts.
Differential localization of tubulin in control and abLIM1-overexpressing osteoclasts
Next, we examined the staining pattern of actin and tubulin in control and abLIM1-overexpressing osteoclasts. In control osteoclasts, EGFP was mainly detected in the cytoplasm (Fig. 4A) . Staining of actin was detected along the periphery of the cells (Fig.   4A ), whereas that of the tubulin was detected throughout the cytoplasm. (Fig. 4B ). However, in abLIM1-overexpressing osteoclasts, EGFP was detected along the cell periphery, which was co-localized with the actin (Fig. 4C) . Staining of tubulin was also observed along with the actin, and expanding tubulin formation was not detected (Fig. 4D ).
Impaired migration of abLIM1-overexpressing osteoclasts
We examined the migration of control and abLIM1-overexpressing RAW-D cells before and after stimulation with RANKL by phase-contrast microscopy. Three days after stimulation, the migration of abLIM1-overexpressing cells was decreased compared to that of control cells (Fig. 5A ). The total cell migration distance and rate of abLIM1-overexpressing cells were significantly lower than those of control cells ( Fig. 5B and C). These results indicate that overexpression of abLIM1 causes impaired migration of osteoclasts. The movies of migration of control and abLIM1-overexpressing RAW-D cells have also been provided (Supplement Data 1 and 2).
Knockdown of abLIM1 enhances the formation of larger and multinucleated osteoclasts
To confirm the role of abLIM1 during osteoclastogenesis, we performed knockdown experiments using siRNA transfection in RAW-D cells. We examined the knockdown efficacy of abLIM1 in RAW-D macrophages by three types of siRNAs (Fig. 6A ). Depletion by siRNA #1 in the RAW-D macrophages showed approximately 50% reduction, while siRNA #2 showed approximately 70% reduction, as compared to that by control siRNA (Fig. 6A) . However, siRNA #3 had no reduction activity (data not shown). Therefore, we selected siRNA #2 for following knockdown experiments. TRAP staining showed that abLIM1 knockdown resulted in the formation of remarkably larger osteoclasts upon culture for 5 days after stimulation with RANKL (Fig. 6B) . The number of TRAP-positive osteoclasts was significantly higher in abLIM1-knockdown osteoclasts than in control cells (Fig. 6C) . Moreover, the nuclear number of abLIM1-knockdown osteoclasts was higher than that of control osteoclasts (Fig. 6D) . Control osteoclasts containing less than 10 nuclei accounted for 90% of the total number, while those containing 11-20 nuclei accounted for 5%. However, abLIM1-knockdown osteoclasts containing more than 21-50 accounted for 8.9% of the total number, while those containing more than 51 nuclei accounted for 3% (Fig. 6D) .
Similar results were observed in the native bone-marrow macrophages (BMMs).
TRAP staining indicated that abLIM1-knockdown osteoclasts derived from BMMs were larger than the control osteoclasts (Fig. S1A ). abLIM1-knockdown led to lower expression by approximately 60% than that of the control siRNA (Fig. S1B) . The number of TRAP-positive multinucleated cells was comparable between abLIM1-depleted BMMs and control cells at three days (Fig. S1C ).
abLIM1 knockdown enlarges resorption area
We further examined the bone resorption of control and abLIM1-knockdown osteoclasts by pit formation assay. Upon determining the resorption areas in both types, the resorption area by abLIM1-depleted osteoclasts was about 4-fold larger than that by control osteoclasts (Fig. 6E) . The calculated data of the resorption area in both types was shown in Fig. 6F . These results indicate that the enlarged resorption area is probably due to the enhanced cell size in abLIM1-knockdown osteoclasts. 
abLIM1 knockdown markedly increases marker gene expression in osteoclasts
abLIM1 knockdown affects tubulin localization, migration, and fusion in osteoclasts
We further observed localization of actin and tubulin in control and abLIM1-knockdown osteoclasts (Fig. 8) . abLIM1-knockdown osteoclasts displayed eccentrically located tubulin in the cytoplasm, while control osteoclasts showed moderate tubulin formation (Fig. 8B) . Staining of actin was observed along the cell periphery in control and abLIM1-knockdown osteoclasts ( Fig. 8A and B) . However, the actin formation in abLIM1-knockdown osteoclasts was rough (Fig. 8B) ., while that in control osteoclasts was smooth (Fig. 8A ).
We finally monitored the migration of abLIM1-knockdown osteoclasts derived from RANKL-induced RAW-D macrophages by phase-contrast microscopy. Migration of abLIM1-depleted multinucleated cells was increased, compared with that of control cells (Fig. 9) . It should be noted that multinucleation appeared in abLIM1-knockdown cells (arrow indicated), but was rare in the control cells (Fig. 9A ). Both total cell migration distance and rate of abLIM1-depleted cells were significantly higher than those of control cells ( Fig. 9B and C) . The movies of migration of control and abLIM1-knockdown RAW-D cells have also been provided (Supplement Data 3 and 4). , 1997) . In the case of humans, abLIM1 splicing is associated with genetic disorders (Ohsawa et al., 2015) . An exon 11 inclusion isoform of abLIM1 is expressed in the skeletal muscle and heart of normal individuals, but not in the skeletal muscle of patients with myotonic dystrophy type 1 (Ohsawa et al., 2015) . It is likely that the tissue-or cell-specific isoforms have specialized roles in cellular processes, such as morphogenesis and differentiation. Consistent with this notion, we discovered the osteoclast-specific isoform abLIM-OCLs during osteoclast differentiation. (Kikuta and Ishii, 2013) . Therefore, it is reasonable to speculate that rapid cell migration and aggregation mediated by abLIM1 enhance cell-cell fusion, resulting in rapid osteoclastogenesis.
So far, the physiological functions of abLIM1 in mammals are poorly understood. This is partially due to abLIM-L knockout mice displaying no phenotypes of development and maturation of retinofugal projections (Lu et al., 2003) . Concerning the function of abLIM proteins, UNC115, the orthologous gene of abLIM1, has been well studied in
Caenorhabditis elegans (Gitai et al., 2003; Lundquist et al., 1998) . For example, UNC115/abLIM in C. elegans regulates the formation of lamellipodia and filopodia, resulting in neuronal morphogenesis (Yang and Lundquist, 2005) . Recent genetic studies have shown that UNC-115/abLIM directly associates with Receptor for Activated C Kinase (RACK-1), and thereby regulation of the actin cytoskeleton and lamellipodia and filopodia formation in migrating cells (Demarco and Lundquist, 2010) . Considering that RACK1
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